keyword
https://read.qxmd.com/read/38638040/hedyotis-diffusa-willd-and-astragalus-membranaceus-may-exert-anti-colon-cancer-effects-by-affecting-akti-expression-as-determined-by-network-pharmacology-and-molecular-docking
#1
JOURNAL ARTICLE
Jianwei Ren, Zhiting Mo, Zhengsha Huang, Shangze Li
BACKGROUND: Network pharmacology is a novel approach that uses bioinformatics to predict multitarget drugs and ingredient-target interactions in various diseases. A thorough search of previously published studies revealed that Hedyotis diffusa Willd (HDW) and Astragalus membranaceus (AM) possess anticancer activity. Colon cancer (CC) is one of the most common malignant tumors of the digestive tract and occurs in the colon. Herein, we explored the effect of two drugs in the treatment of CC...
April 17, 2024: Current Computer-aided Drug Design
https://read.qxmd.com/read/38625017/dysregulated-lipid-metabolism-networks-modulate-t-cell-function-in-people-with-relapsing-remitting-multiple-sclerosis
#2
JOURNAL ARTICLE
Lucia Martin-Gutierrez, Kirsty E Waddington, Annalisa Maggio, Leda Coelewij, Alexandra Oppong, Nina Yang, Marsilio Adriani, Petra Nytrova, Rachel Farrell, Inés Pineda-Torra, Elizabeth C Jury
Altered cholesterol, oxysterol, sphingolipid, and fatty acid concentrations are reported in blood, cerebrospinal fluid, and brain tissue of people with relapsing remitting multiple sclerosis (RRMS) and are linked to disease progression and treatment responses. CD4+ T cells are pathogenic in RRMS, and defective T cell function could be mediated in part by liver X receptors (LXRs) - nuclear receptors that regulate lipid homeostasis and immunity. RNA-sequencing and pathway analysis identified that genes within the 'lipid metabolism' and 'signalling of nuclear receptors' pathways were dysregulated in CD4+ T cells isolated from RRMS patients compared with healthy donors...
April 16, 2024: Clinical and Experimental Immunology
https://read.qxmd.com/read/38616886/the-role-of-interleukin-23-17-axis-in-psoriasis-management-a-comprehensive-review-of-clinical-trials
#3
REVIEW
Luca Potestio, Fabrizio Martora, Giuseppe Lauletta, Ylenia Vallone, Teresa Battista, Matteo Megna
Psoriasis pathogenesis is influenced by genetic factors and characterized by a complex interplay between genetic predisposition and various environmental triggers. These triggers set off metabolic processes involving inflammation, cell signaling, immune response dysregulation, and antigen presentation. Several types of innate and adaptive immune cells are involved in psoriasis. Among the cytokine cascade which leads to psoriasis development, the interleukin (IL)-23/Th17 axis, especially IL-17 production, emerges as crucial...
2024: Clinical, Cosmetic and Investigational Dermatology
https://read.qxmd.com/read/38610706/biological-therapy-for-psoriasis-in-cancer-patients-an-8-year-retrospective-real-life-study
#4
JOURNAL ARTICLE
Teresa Battista, Lucia Gallo, Fabrizio Martora, Davide Fattore, Luca Potestio, Sara Cacciapuoti, Massimiliano Scalvenzi, Matteo Megna
Background : It is now recognized that psoriasis plays a key role in the development of several comorbidities, such as cardiovascular disease, and metabolic syndrome. Some authors have hypothesized that patients with psoriasis may have an increased risk of developing certain types of cancer. The efficacy and safety of biologic drugs are well-documented in clinical trials and in real-life studies. However, there is limited evidence on the safety of the use of biologic treatments in cancer patients with psoriasis, and the use of this therapeutic class in patients with a pre-existing or concomitant malignancy is still debated...
March 27, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38607060/the-natural-product-secoemestrin-c-inhibits-colorectal-cancer-stem-cells-via-p38-s100a8-feed-forward-regulatory-loop
#5
JOURNAL ARTICLE
Huimin Zhou, Minghua Chen, Cong Zhao, Rongguang Shao, Yanni Xu, Wuli Zhao
Cancer stem cells (CSCs) are closely associated with tumor initiation, metastasis, chemoresistance, and recurrence, which represent some of the primary obstacles to cancer treatment. Targeting CSCs has become an important therapeutic approach to cancer care. Secoemestrin C (Sec C) is a natural compound with strong anti-tumor activity and low toxicity. Here, we report that Sec C effectively inhibited colorectal CSCs and non-CSCs concurrently, mainly by inhibiting proliferation, self-renewal, metastasis, and drug resistance...
April 3, 2024: Cells
https://read.qxmd.com/read/38605527/haematopoietic-innate-interleukin-17a-production-drives-immunopathology-in-female-mouse-genital-chlamydia-muridarum-infection
#6
JOURNAL ARTICLE
Charles W Armitage, Emily R Bryan, Logan Trim, Ella Palframan, Lucas Wager, Kenneth W Beagley, Alison J Carey
Chlamydia trachomatis infection is the leading cause of bacterial urogenital infection and has been demonstrated to drive inflammation and scarring of the reproductive tract. Recent studies have identified key triggers of proinflammatory adaptive immune responses driven by innate leukocytes and epithelia driving immunopathology. Utilizing chimeric mouse models, we investigated the definitive source and role of IL17 and IL17 signalling receptors during early Chlamydia muridarum infection of the female urogenital tract...
May 2024: Scandinavian Journal of Immunology
https://read.qxmd.com/read/38603464/choosing-the-right-biologic-treatment-for-moderate-to-severe-plaque-psoriasis-the-impact-of-comorbidities
#7
REVIEW
Laura L Mateu-Arrom, Lluis L Puig
INTRODUCTION: Psoriasis is a chronic inflammatory skin disease often associated with several comorbidities, such as psoriatic arthritis, inflammatory bowel disease, obesity, diabetes mellitus or cardiovascular diseases, infections, or cancer, among others. With the progressive aging of the population, a growing number of patients with psoriasis can be expected to present multiple comorbidities. Currently, there is a wide range of biological treatments available for moderate to severe psoriasis, including tumor necrosis alpha (TNF) inhibitors, IL12/23 inhibitor, IL17 inhibitors, and IL23 inhibitors...
April 11, 2024: Expert Review of Clinical Pharmacology
https://read.qxmd.com/read/38597096/brodalumab-for-moderate-severe-hidradenitis-suppurativa-an-open-label-multicentric-cohort-study-in-real-clinical-practice
#8
JOURNAL ARTICLE
Guiovana Fernanda Osorio-Gómez, Juan Ortiz-Álvarez, Delia Diaz-Ceca, Cesar Guijarro-Sánchez, Julián Conejo-Mir Sánchez, Pablo Fernández Crehuet
INTRODUCTION: The use of biological therapy is becoming increasingly common in patients with hidradenitis suppurativa (HS). Levels of serum TNF-alfa and IL17 support the role of an immune system dysregulation in the pathogenesis of HS. Brodalumab targets the receptor A of IL-17, thus having a promising role in the treatment of HS. MATERIAL AND METHODS: A multicenter retrospective observational open-label study was conducted in two tertiary hospitals. Adults with moderate to severe HS under treatment with brodalumab 210 mg at week 0, 1, 2 and then every 2 weeks were included and assessed at weeks 0 and 16 which was the median follow-up time...
April 10, 2024: Australasian Journal of Dermatology
https://read.qxmd.com/read/38592689/immunological-profiles-in-parry-romberg-syndrome-a-case-control-study
#9
JOURNAL ARTICLE
Irma Saulle, Antonio Gidaro, Mattia Donadoni, Claudia Vanetti, Alessandra Mutti, Maria Eva Romano, Mario Clerici, Chiara Cogliati, Mara Biasin
Background : Parry-Romberg syndrome (PRS) is a rare craniofacial disorder. The aim of this study is to provide information on the immunological profile of this pathology. Since PRS can be included in a wider spectrum of sclerodermic diseases, we propose a case-control study comparing a patient affected by PRS with one with a diagnosis of scleroderma, herein used as control (CTR). Methods : B lymphocyte, T lymphocyte, and monocyte phenotypes and functions were assessed by flow cytometry in influenza (Flu)- or anti cluster differentiation (CD)3/CD28-stimulated peripheral blood mononuclear cells (PBMCs)...
February 21, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38588614/s100a9-exacerbates-sepsis-induced-acute-lung-injury-via-the-il17-nf%C3%AE%C2%BAb-caspase-3-signaling-pathway
#10
JOURNAL ARTICLE
Hui Pei, Jianming Chen, Jie Qu, Zhongqiu Lu
BACKGROUND: Sepsis-induced acute lung injury (ALI) is associated with considerable morbidity and mortality in critically ill patients. S100A9, a key endothelial injury factor, is markedly upregulated in sepsis-induced ALI; however, its specific mechanism of action has not been fully elucidated. METHODS: The Gene Expression Omnibus database transcriptome data for sepsis-induced ALI were used to screen for key differentially expressed genes (DEGs). Using bioinformatics analysis methods such as Gene Ontology, Kyoto Encyclopedia of Genes and Genomes, and protein-protein interaction network analyses, the pathogenesis of sepsis-induced ALI was revealed...
March 26, 2024: Biochemical and Biophysical Research Communications
https://read.qxmd.com/read/38582897/extracellular-vesicle-encapsulated-homer1a-as-novel-nanotherapeutics-against-intracerebral-hemorrhage-in-a-mouse-model
#11
JOURNAL ARTICLE
Xiaowei Fei, Li Wang, Ya-Nan Dou, Fei Fei, Yanyu Zhang, Weihao Lv, Xin He, Xiuquan Wu, Wangshu Chao, Hongqing Chen, Jialiang Wei, Dakuan Gao, Zhou Fei
Homer1a and A2 astrocytes are involved in the regulation of inflammation induced by intracerebral hemorrhage (ICH). However, there is no anticipated treatment strategy based on the anti-inflammatory effect of Homer1a and A2 astrocytes. Here, we successfully induced A2 astrocytes in vitro, and then we report an efficient method to prepare Homer1a+ EVs derived from A2 astrocytes which making it more stable, safe, and targetable to injured neurons. Homer1a+ EVs promotes the conversion of A1 to A2 astrocytes in ICH mice...
April 6, 2024: Journal of Neuroinflammation
https://read.qxmd.com/read/38575111/cmtm4-deficiency-exacerbates-colitis-by-inducing-gut-dysbiosis-and-s100a8-9-expression
#12
JOURNAL ARTICLE
Qiao Meng, Jing Ning, Jingjing Lu, Jing Zhang, Ming Zu, Jing Zhang, Xiurui Han, Huiling Zheng, Yueqing Gong, Xinyu Hao, Ying Xiong, Fang Gu, Wenling Han, Weiwei Fu, Jun Wang, Shigang Ding
The dysfunction of innate immunity components is one of the major drivers for ulcerative colitis (UC), and increasing reports indicate that gut microbiome serves as an intermediate between genetic mutations and UC development. Here, we find that the IL-17 receptor subunit, CMTM4, is reduced in UC patients and DSS-induced colitis. The deletion of CMTM4 (Cmtm4-/- ) in mice leads to a higher susceptibility to DSS-induced colitis in comparison to wildtype, and the gut microbiome significantly changes in the composition...
April 2, 2024: Journal of Genetics and Genomics
https://read.qxmd.com/read/38574366/discovery-of-small-molecule-interleukin-17a-inhibitors-with-novel-binding-mode-and-stoichiometry-optimization-of-dna-encoded-chemical-library-hits-to-in-vivo-active-compounds
#13
JOURNAL ARTICLE
Ashley L Ramos, Eric R Goedken, Kristine E Frank, Maria A Argiriadi, Sana Bazzaz, Zhiguo Bian, Jesse T C Brown, Paolo A Centrella, Hui-Ju Chen, Jeremy S Disch, Pamela L Donner, David B Duignan, Diana Gikunju, Stephen N Greszler, Marie-Aude Guié, Sevan Habeshian, Hajnalka E Hartl, Christopher D Hein, Charles W Hutchins, Rachael Jetson, Anthony D Keefe, Hasan Khan, Huan-Qiu Li, Allison Olszewski, Benjamin J Ortiz Cardona, Augustine Osuma, Sanjay C Panchal, Ryan Phelan, Wei Qiu, J Brad Shotwell, Anurupa Shrestha, Myron Srikumaran, Zhi Su, Chaohong Sun, Anup K Upadhyay, Michael D Wood, Haihong Wu, Ruijie Zhang, Ying Zhang, Gang Zhao, Haizhong Zhu, Matthew P Webster
Dysregulation of IL17A drives numerous inflammatory and autoimmune disorders with inhibition of IL17A using antibodies proven as an effective treatment. Oral anti-IL17 therapies are an attractive alternative option, and several preclinical small molecule IL17 inhibitors have previously been described. Herein, we report the discovery of a novel class of small molecule IL17A inhibitors, identified via a DNA-encoded chemical library screen, and their subsequent optimization to provide in vivo efficacious inhibitors...
April 4, 2024: Journal of Medicinal Chemistry
https://read.qxmd.com/read/38541607/bimekizumab-short-term-effectiveness-and-safety-in-real-clinical-practice-in-andalucia-spain
#14
JOURNAL ARTICLE
Ricardo Ruiz-Villaverde, Lourdes Rodriguez-Fernandez-Freire, Marta Cebolla-Verdugo, Alvaro Prados-Carmona, Carlos Hernández-Montoya, José Carlos Armario-Hita, Manuel Galán-Gutiérrez
Introduction : Psoriasis, a chronic inflammatory skin disease, affects 2-10% of the population globally. Bimekizumab (BMK), a monoclonal antibody targeting IL-17, is a dual inhibitor of IL17 A and F that has shown efficacy in treating moderate to severe plaque psoriasis. This real-world evidence (RWE) study aims to assess BMK's efficiency and safety in naïve and refractory patients. Material and methods: A retrospective analysis of a multicenter observational study included 22 patients treated with BMK from April 2023 to February 2023 in five Andalusian hospitals...
February 20, 2024: Life
https://read.qxmd.com/read/38536611/heterologous-expression-of-human-ifn%C3%AE-and-anti-il17-antibody-in-leishmania-tarentolae-promastigote
#15
JOURNAL ARTICLE
Arian Karimi Rouzbahani, Seyedeh-Zeinab Hosseini, Mojgan Bandehpour, Bahram Kazemi, Afsaneh Tavasoli, Amirreza Javadi Mamaghani, Farnaz Kheirandish
BACKGROUND: Leishmania is an intracellular flagellate protozoan parasite that causes a wide range of clinical diseases in humans. The basis of immunological resistance against leishmaniasis depends on Thl reactions and is within the time period of cytokine function. METHODS: In this study, human anti-IL17 antibody and IFNγ-producing promastigote were produced to be used in leishmanization. A sequence of light and heavy chains' gene of anti-IL17 antibody and human IFNγ (hIFNγ) was obtained from the NCBI database and synthesized in the ECORV reaction site in the plasmid pGH, which it's called pGH-hIFNγ-antiIL17...
March 27, 2024: Acta Parasitologica
https://read.qxmd.com/read/38533033/elucidating-the-anti-cancer-potential-of-cinnamomum-tamala-essential-oil-against-non-small-cell-lung-cancer-a-multifaceted-approach-involving-gc-ms-profiling-network-pharmacology-and-molecular-dynamics-simulations
#16
JOURNAL ARTICLE
Debajani Mohanty, Sucheesmita Padhee, Arpita Priyadarshini, Bibhuti Bhusan Champati, Prabhat Kumar Das, Sudipta Jena, Ambika Sahoo, Pratap Chandra Panda, Sanghamitra Nayak, Asit Ray
Cinnamomum tamala (Buch.-Ham.) T.Nees & Eberm., or Indian Bay Leaf, is a well-known traditional ayurvedic medicine used to treat various ailments. However, the molecular mechanism of action of Cinnamomum tamala essential oil (CTEO) against non-small cell lung cancer (NSCLC) remains elusive. The present study aims to decipher the molecular targets and mechanism of CTEO in treating NSCLC. GC-MS analysis detected 49 constituents; 44 successfully passed the drug-likeness screening and were identified as active compounds...
March 30, 2024: Heliyon
https://read.qxmd.com/read/38531177/dual-blockade-of-interleukin-17a-and-interleukin-17f-as-a-therapeutic-strategy-for-liver-fibrosis-investigating-the-potential-effect-and-mechanism-of-brodalumab
#17
JOURNAL ARTICLE
Kazuki M Matsuda, Hirohito Kotani, Teruyoshi Hisamoto, Ai Kuzumi, Takemichi Fukasawa, Asako Yoshizaki-Ogawa, Shinichi Sato, Ayumi Yoshizaki
Liver fibrosis is a terminal manifestation of various chronic liver diseases. There are no drugs that can reverse the condition. Recently, the importance of interleukin-17 (IL17) in the pathophysiology has been revealed and has attracted attention as a therapeutic target. We aimed to reveal the roles of IL17A and IL17F in liver fibrosis, and to validate the potential of their dual blockade as therapeutic strategy. First, we retrospectively reviewed the longitudinal change of FIB-4 index, a clinical indicator of liver fibrosis, among psoriasis patients treated by brodalumab, which blocks IL17 receptor A (IL17RA)...
March 25, 2024: Cytokine
https://read.qxmd.com/read/38530897/innate-like-t-cell-subset-commitment-in-the-murine-thymus-is-independent-of-tcr-characteristics-and-occurs-during-proliferation
#18
JOURNAL ARTICLE
Vadim K Karnaukhov, Anne-Laure Le Gac, Linda Bilonda Mutala, Aurélie Darbois, Laetitia Perrin, Francois Legoux, Aleksandra M Walczak, Thierry Mora, Olivier Lantz
How T-cell receptor (TCR) characteristics determine subset commitment during T-cell development is still unclear. Here, we addressed this question for innate-like T cells, mucosal-associated invariant T (MAIT) cells, and invariant natural killer T (iNKT) cells. MAIT and iNKT cells have similar developmental paths, leading in mice to two effector subsets, cytotoxic (MAIT1/iNKT1) and IL17-secreting (MAIT17/iNKT17). For iNKT1 vs iNKT17 fate choice, an instructive role for TCR affinity was proposed but recent data argue against this model...
April 2, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38514921/high-fat-diet-induced-obesity-causes-intestinal-th17-treg-imbalance-that-impairs-the-intestinal-barrier-and-aggravates-anxiety-like-behavior-in-mice
#19
JOURNAL ARTICLE
Yao Cai, Wenlin Deng, Qiuping Yang, Guixian Pan, Zao Liang, Ximei Yang, Sitao Li, Xin Xiao
The prevalence of autism spectrum disorders (ASD) has been steadily increasing, and growing evidence suggests a link between high-fat diet (HFD), obesity, and ASD; however, the mechanism underlying this association remains elusive. Herein, BTBR T + tf/J (BTBR) inbred mice (a mouse ASD model) and C57Bl/6J (C57) mice were fed an HFD and normal diet (ND) for 8 weeks (groups: C57 + ND, C57 + HFD, BTBR + ND, and BTBR + HFD). Subsequently, mice underwent behavioral assessments, followed by intestinal tissues harvesting to detect expression of intestinal barrier proteins and inflammatory factors and immune cell numbers, and a correlation analysis...
March 30, 2024: International Immunopharmacology
https://read.qxmd.com/read/38506123/identification-of-inflammatory-mediators-in-saliva-samples-from-hospitalized-newborns-potential-biomarkers
#20
JOURNAL ARTICLE
Vanderlei Amadeu da Rocha, Sanseray da Silveira Cruz-Machado, Isília Aparecida Silva, Pedro Augusto Carlos Magno Fernandes, Regina Pekelmann Markus, Mariana Bueno
UNLABELLED: Saliva measurements serve as a noninvasive tool for clinically monitoring newborns (NB) and children, a vulnerable population with promising potential for both research and clinical practice. Saliva acts as a repository for various inflammatory biomarkers involved in diverse biological functions. Particularly for children, it offers numerous advantages when compared to plasma and urine sampling. Nevertheless, there is a significant knowledge gap regarding detectable levels of cytokines in the saliva of newborns and children, as well as studies aiming to assess the relationship of this content with physiological and pathological processes...
March 20, 2024: Clinical Nursing Research
keyword
keyword
24749
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.